title: A 'BOLD' experiment in defining the utility of fMRI in drug development.
authors.affiliation: Imaging Consortium for Drug Development, Brain Imaging Center, McLean Hospital, Belmont, USA. dborsook@partners.org
authors.forename: David
authors.initials: D
authors.lastname: Borsook
authors.forename: David
authors.initials: D
authors.lastname: Bleakman
authors.forename: Richard
authors.initials: R
authors.lastname: Hargreaves
authors.forename: Jaymin
authors.initials: J
authors.lastname: Upadhyay
authors.forename: Karl F
authors.initials: KF
authors.lastname: Schmidt
authors.forename: Lino
authors.initials: L
authors.lastname: Becerra
mesh_terms: D001921:Brain / Q000187:drug effects* / Q000503:physiopathology*; D001927:Brain Diseases / Q000188:drug therapy* / Q000503:physiopathology*; D002986:Clinical Trials as Topic / Q000379:methods*; D004341:Drug Evaluation / Q000379:methods*; D006801:Humans; D008279:Magnetic Resonance Imaging / Q000379:methods*; D018696:Neuroprotective Agents / Q000008:administration & dosage*; D014481:United States
chemical_list: D018696:Neuroprotective Agents